PRFX Stock Analysis: Buy, Sell, or Hold?
$0.74
-0.05 (-6.69%)
âŧ
5d:
-2.81%
30d:
-9.11%
90d:
-38.04%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (77%)
Quality Score
51/100
Position
SLIGHTLY LOW
30-Day Fair Range
$0.73 â $0.85
Position: SLIGHTLY LOW
Wall Street Target
$12.00
+1514.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.64 / $0.89
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: PRFX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When PRFX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: PRFX is currently trading at $0.74, which is considered slightly low relative to its 30-day fair value range of $0.73 to $0.85.
Technical Outlook: Technically, PRFX is in a strong downtrend. Immediate support is located at $0.64, while resistance sits at $0.89. Short-term momentum is weak, with the stock down 6.7% recently.
Market Sentiment: The stock scores a mixed 54/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $12.00 (+1514.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PRFX is in a strong downtrend. Immediate support is located at $0.64, while resistance sits at $0.89. Short-term momentum is weak, with the stock down 6.7% recently.
Market Sentiment: The stock scores a mixed 54/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $12.00 (+1514.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.73 -
$0.85
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
Trading Range & Key Levels
30-Day Trading Range
$0.73 -
$0.85
Current vs Trading Range
SLIGHTLY LOW
Support Level
$0.64
Resistance Level
$0.89
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (54/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.7%)
- BULLISH: Trading 1514.0% below Wall St target ($12.00)
- WARNING: Composite score 51/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Wall Street Target
$12.00
(+1514.0%)
Share PRFX Analysis
Share this live PRFX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (PRFX)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits shows 100.0% bullish sentiment toward $PRFX with no recent news articles available.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 7:38 AM ET
Data refreshes hourly during market hours. Next update: 8:38 AM
Data refreshes hourly during market hours. Next update: 8:38 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRFX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences IâĻ |
STRONG BUY
29 analysts |
$208 | 23 SELL |
|
ALKS
Alkermes Plc |
STRONG BUY
20 analysts |
$58 | 33 SELL |
|
AQST
Aquestive Therapeutics IâĻ |
STRONG BUY
9 analysts |
$9 | 62 BUY |
|
UTHR
United Therapeutics CorpâĻ |
STRONG BUY
15 analysts |
$687 | 52 HOLD |
|
HROW
Harrow Health Inc |
STRONG BUY
9 analysts |
$63 | 53 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive PRFX Research Pages
